Coronary Heart Disease Risk in Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Coronary Heart DiseaseType 2 Diabetes
Interventions
BEHAVIORAL

Self-Management Intervention

The SMI will incorporate a discussion to introduce self-management and why it is important, and about problems associated with reducing CHD risk and managing type 2 diabetes. Specific topics addressed will include health behaviours to reduce CHD risk and manage diabetes including diet and exercise, as well as behaviours specific to managing diabetes, including medication adherence and self-care behaviours (e.g. footcare). Sessions are patient-directed and employ a shared decision-making approach, such that participants work with one another and the practice nurse facilitator to identify specific problems that they wish to address, and to identify solutions and approaches to managing their diabetes and CHD risk

BEHAVIORAL

Risk Result

Participants will receive in-person personalised feedback about their combined genetic and lifestyle 10 year risk for developing CHD.

Trial Locations (10)

CM20 1DS

Addison House Surgery, Harlow

SG12 9EG

Church Street Surgery, Ware

SG12 9HJ

Dolphin House Surgery, Ware

SG14 1HZ

Wallace House Surgery, Hertford

PE27 4LG

Cambridgeshire Community Services NHS Trust, Cambridgeshire

IP1 6DW

Chesterfield Drive Surgery, Ipswich

IP5 3SL

Martlesham health Surgery, Ipswich

IP12 1EE

Dr Taylor and Partners, Woodbridge Suffolk

IP12 2NN

The Peninsula Practice, Woodbridge Suffolk

IP13 0SB

Wickham Market Medical Centre, Woodbridge Suffolk

All Listed Sponsors
collaborator

University College, London

OTHER

lead

City, University of London

OTHER

NCT01891786 - Coronary Heart Disease Risk in Type 2 Diabetes | Biotech Hunter | Biotech Hunter